BLOG/🇺🇸United States··daily

Significant Contract Modifications ($10M+) — March 05, 2026

Significant Contract Modifications ($10M+)

20 total filings analysed

Executive Summary

This period's $6.6B in significant contract modifications is dominated by a $2.87B NASA award to Lockheed Martin for space vehicle components, signaling sustained aerospace demand despite historical dates and zero outlays across many contracts. Bullish signals prevail (16/20) in emerging nuclear (HALEU at $900M to General Matter), healthcare IT (Optum $724M VA, GD IT $146M CMS), and federal IT services, with options adding $2B+ potential upside. Risks center on execution delays ($0 outlays common), firm-fixed-price margin pressures, and ended performance periods limiting near-term cash flows.

Tracking the trend? Catch up on the prior Significant Contract Modifications ($10M+) digest from March 04, 2026.

Investment Signals(5)

  • Aerospace primes secure massive NASA backlog(HIGH)

    Lockheed Martin ($2.87B + $52M options) and others (Hamilton Sundstrand $248M, Amentum $179M) highlight trusted incumbency in space vehicle components despite aged contracts.

  • HALEU production ramps domestic nuclear capacity(HIGH)

    General Matter's $900M DOE award (up to $1.135B options) for 10-year HALEU UF6 production positions small biz for recurring nuclear fuel revenue amid energy security push.

  • Healthcare IT delivery orders provide multi-year visibility(MEDIUM)

    Optum ($724M VA managed care), GD IT ($146M CMS HIGLAS to $476M potential), and Deloitte ($86M NIH UCC) signal steady fed healthcare tech spending through 2027+.

  • Federal IT incumbents win large GSA/DHS task orders(HIGH)

    Leidos ($123M Army network to $331M), ManTech ($116M + $154M State IT), Palantir ($145M ICE case mgmt), and others aggregate $700M+ with extensions to 2029.

  • Zero outlays plague 70%+ of obligations(HIGH)

    15/20 contracts show $0 outlayed despite $5B+ totals, indicating data lags, funding delays, or completions without cash realization.

Risk Flags(4)

  • Execution[HIGH RISK]

    Firm-fixed-price structures (11/20 contracts) expose contractors to cost overruns/inflation over long periods (e.g., Pernix 6yrs, Ameresco 25yrs).

  • Execution[CRITICAL RISK]

    Historical/ended performance periods (7/20, e.g., Lockheed 2013 end) with $0 outlays question ongoing relevance and cash flow realization.

  • Market[MEDIUM RISK]

    High subawards (e.g., Leidos $134M/123M obligation, SES $70M/85M) pressure prime margins via subcontractor dependencies.

  • Regulatory[MEDIUM RISK]

    Long-term contracts (10+ yrs: General Matter, Ameresco) face budget cycles, policy shifts in nuclear/energy/healthcare.

Opportunities(4)

  • $2B+ unexercised options across portfolio (e.g., ManTech GSA $507M upside, Leidos $208M, GD IT $331M) for revenue expansion.

  • Domestic HALEU buildout enables nuclear supply chain scaling with 10-yr DOE commitment.

  • Extensions on IT/healthcare contracts (e.g., CMS to 2031, VA to 2028) add 2-5 yrs revenue.

  • Small/mid-cap winners (Pernix $365M construction, SES $85M aircraft) beating large primes in open comps.

Sector Themes(4)

  • $3.4B (51%) in NASA space contracts to incumbents like Lockheed, despite aged dates.

  • $900M DOE award anchors domestic fuel production amid uranium security focus.

  • $1.8B+ in delivery orders (GSA, VA, DHS, CMS) with long tails to 2029-31.

  • Ameresco/Honeywell $142M+ GSA for 8-25yr building upgrades.

Watch List(6)

  • 👁

    {"entity"=>"Lockheed Martin", "reason"=>"$2.87B NASA tank production dominates dataset but $0 outlay/ended period raises realization doubts.", "trigger"=>"Outlay increases or new space awards"}

  • 👁

    {"entity"=>"General Matter", "reason"=>"$900M HALEU small-biz win positions for nuclear boom; 10-yr term with $235M options.", "trigger"=>"Production start, option exercises"}

  • 👁

    {"entity"=>"UnitedHealth (Optum)", "reason"=>"$724M VA healthcare IT fully obligated, signals fed payer expansion.", "trigger"=>"Outlays commence post-Mar 2026 award"}

  • 👁

    {"entity"=>"Leidos", "reason"=>"$123M Army IT (to $331M potential) amid high subawards; GSA vehicle strength.", "trigger"=>"Option funding, margin updates"}

  • 👁

    {"entity"=>"ManTech", "reason"=>"Dual $270M+ wins (GSA eng, State IT) with massive options upside.", "trigger"=>"FY26 outlays, extensions to 2028"}

  • 👁

    {"entity"=>"Palantir", "reason"=>"$145M DHS ICE case mgmt with 60% outlayed, validates software platform stickiness.", "trigger"=>"Extension to 2027, new agency wins"}

Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 20 filings

🇺🇸 More from United States

View all →
Significant Contract Modifications ($10M+) — March 05, 2026 | Gunpowder Blog